Scinovex
review Open AccessTop 1% cited

British Thoracic Society guideline for non-CFbronchiectasis

Thorax · 2010 · Vol. 65(Suppl 1) · pp. i1–i58
M. C. PasteurDiana BiltonAdam T. Hillon behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group

Abstract

The diagnosis, investigation and particularly management of bronchiectasis has been largely empirical and the subject of relatively few controlled clinical trials. There are no clear guidelines, although an Australian position statement has been published concerning bronchiectasis in children. The purposes of these guidelines were therefore threefold: (1) to identify relevant studies in non-cystic fibrosis (CF) bronchiectasis; (2) to provide guidelines on management based on published studies where possible or a consensus view; and (3) to identify gaps in our knowledge and identify areas for future study.

Cystic Fibrosis Research AdvancesTracheal and airway disordersNeonatal Respiratory Health ResearchMedicineBronchiectasisGuidelineIntensive care medicineStatement (logic)Position statementSubject (documents)Family medicinePathologyLung

MeSH terms

Administration, InhalationAdultAnti-Bacterial AgentsBronchiectasisChildCystic FibrosisDiagnostic Techniques, Respiratory SystemHumansInfusions, IntravenousNebulizers and VaporizersRespiratory Function TestsTomography, X-Ray ComputedRespiratory System AgentsEvidence-Based MedicinePhysical Therapy Modalities
Citations
1,045
FWCI
35.12
field-weighted impact
References
592
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.